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Abstract
Background: A higher risk of common mental health disorders has been found for first-generation migrants in
high income countries, but few studies have examined the use of mental health care. This study aimed to identify
the level of antidepressant use amongst the largest first generation migrant groups resident in Finland.
Methods: This cohort study used record-based data linkage methodology to examine the hazard of antidepressant
use between migrant groups in Finland using Cox proportional hazard models. Data was derived using socio-
demographic and prescription data from Statistics Finland and the Finnish Population Registry. The cohort included
a random sample of 33% of the working age population in 2007 (N = 1,059,426, 49.8% women, 2.5% migrants) and
dispensed antidepressant prescriptions from 2008 to 2014.
Results: After adjustment for socio-demographic characteristics, results show higher antidepressant use for female
migrants from North Africa and the Middle East compared to the Finland-born majority, a similar level of use for
migrants from Western countries, and lower use for migrants from other non-Western countries.
Conclusions: The gender and country of origin dependent use of antidepressant medication is discussed in terms
of socio-political and cultural between-group differences. Recommendations are made to address inequalities in
accessing services, particularly for migrants from non-Western countries.
Keywords: Migrants, Finland, Mental health, Antidepressants
Background
The higher incidence of common mental health disorders
amongst first-generation migrants living in high income
countries compared to the settled majority population has
been clearly established [1–3]. The incidence of depres-
sion and anxiety has been estimated at 14% for first gener-
ation migrants living in high income countries, 31% in low
income countries and 44% for refugees and asylum
seekers in both low and high income countries [4]; with
some mixed findings reflecting the diversity of migrant
groups, migration routes, countries of residence, and levels
of social disadvantage, as well as methodological differ-
ences in measuring disorders in these populations [5, 6].
The increased risk has been associated with dispropor-
tionate exposure to a multitude of risk factors, including
social and economic disadvantage [3], and refugee status
[2]. Despite the well-established evidence of an increased
risk of common mental health disorders in first-
generation migrants, their level of access to, and use of,
mental health care is less understood.
Multiple studies have found an underuse of mental
health services by first generation migrants compared to
the settled majority [7, 8] which has been explained by
poorer knowledge of how to access services, stigma in
reporting mental health difficulties, and limited cultural
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competencies of service providers [9]. However, findings
have shown a mixed picture in use of services for differ-
ent types of care and for different migrant groups.
Greater psychiatric hospital admission for female immi-
grants was found in Sweden [10] and for refugees from
Yugoslavia and the Middle East in Denmark [11]. This
higher risk is echoed by research using antidepressant
medication prescriptions, for refugee groups in Sweden
particularly for refugees from the Horn of Africa [7]. A
review of these studies found a trend in which higher
use of mental health service was linked with involuntary
admissions, whilst lower use was linked with voluntary
admissions or primary care services [3], with the excep-
tion of a study conducted in the Netherlands where mi-
grant use of outpatient mental health care was found to
be higher than for Dutch nationals [12]. These contrast-
ing findings indicate that the use of mental health ser-
vices by migrants is dependent on the country of origin,
the host country, and the type of care. The unclear find-
ings for primary care are particularly unsettling as access
to this level of care can have a preventive function, in
both reducing the risk of worsening symptoms and re-
ducing the burden on secondary and tertiary services
[13]. It remains unclear to what extent different first-
generation migrant group resident in high-income coun-
tries are able to access, and use, mental health care for
affective disorders.
Finland, with a growing migrant population that now
makes up 5.9% of the population [14, 15], benefits from
a universal health care system and a comprehensive
population registry that collect and maintain high-
quality data on the social, economic, and health charac-
teristics of the population, providing an opportunity for
robust epidemiological research. Research on mental dis-
orders in Finland has found a higher risk of self-reported
depression among Kurdish and Russian migrants than
the Finnish average, but no difference for Somali mi-
grants [14]. This may be because of the high non-
response rate for Somalian migrants in the study, and a
high level of mental health stigma amongst Somalian mi-
grant populations in general, that may have led to
under-reporting of mental health difficulties [15]. The
overall findings are in line with research in other coun-
tries [1]. In terms of service use, a recent register-based
study using hospital discharge data in Finland, indicated
a lower use of hospital services for migrant groups, with
the exception of migrants from North Africa and the
Middle East who had a higher use, and migrants from
Nordic and Eastern European countries who had a simi-
lar level of use to the Finnish-born population [16]. The
lower use of hospital services by some migrant groups is
in contrast to previous research in other country con-
texts [13], and may reflect different pathways of access
for migrant groups in Finland. However, to the author’s
knowledge no study has yet looked at the use of primary
care services in first-generation migrants in Finland.
The mixed findings for different service types, migrant
groups, and receiving societies, limit our understanding
of social and mental health inequalities in these popula-
tions and underlines the need for comprehensive and ro-
bust research to inform mental health service policy and
resource allocation. Data on prescribed antidepressant
medication linked to country of birth and socio-
demographic characteristics, covering a large random
sample of the working-age population of Finland, allows
for a robust and high quality study on migrants use of
voluntary primary mental health care for affective disor-
ders in Finland. The scale of the data provides a large
enough sample size to include multiple migrant group-
ings, reducing the heterogeneity of groups in previous
studies, as well as providing a large and representative
cohort that can be generalised to the rest of the migrant
population with confidence. Furthermore, the long fol-
low up of 7 years overcomes the limitations of cross-
sectional research designs, and the provision of highly
accurate linked socio-demographic characteristics allows
for the adjustment of some key risk factors in the eti-
ology of affective disorders. Using this large-scale data
linkage methodology, this study therefore aimed to iden-
tify the likelihood of antidepressant use between 2008
and 2014 amongst the largest migrant groups resident in
Finland.
Methods
Study population and design
This data linkage study used a cohort design with de-
rived variables from high quality databases maintained
by Statistics Finland, including individual socio-
demographic data, and longitudinal reimbursements for
prescription medicines. The databases have high accur-
acy ratings according to the United Nations Statistical
Commission and on the European Statistics Code of
Practice [17], and include data on a 33% representative
sample of the working age (18–64) population of Finland
at the end of 2007 with all outpatient prescriptions dis-
pensed between January 1, 2008 and December 31, 2014.
The use of pharmacy records has been found to be a re-
liable measure of drug exposure [18].
Using unique national personal identification numbers,
participant’s socio-demographic descriptive data was
linked to antidepressant prescription dispensations. As
the study draws on secondary administrative data, which
was checked by Statistics Finland for anonymity and
non-disclosure, participants’ consent was not required.
The study was given ethical approval by the Finnish In-
stitute of Occupational Health and adheres to the ethical
standards set out by the Helsinki Declaration of 1975,
revised in 2008.
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Variable preparation
Antidepressant use
To capture antidepressant use we included all purchases of
antidepressant medication with the Anatomical Thera-
peutic Chemical (ATC) code of N06A, which includes non-
selective monoamine reuptake inhibitors (N06AA), select-
ive serotonin reuptake inhibitors (N06AB), non-selective
monoamine oxidase inhibitors (N06AF), monoamine oxi-
dase A inhibitors (N06AG) and other antidepressants
(N06AX). Antidepressants in combination with psycholep-
tics (N06CA) was not included. Purchases were obtained
between 2005 and 2014 from the Finnish Prescription
Register. The register is maintained by the Social Insurance
Institution and records the date of all drug purchases that
are reimbursed by the Finnish state to permanent residents
in non-institutional settings. The record includes the date
of drug dispensation and the World Health Organization’s
(WHO) ATC code (WHO, 2003). Antidepressant medica-
tion is used for a range of common mental health disorders
including both depressive and anxiety disorders, as well as
for sub-clinical symptoms [19].
In order to access prescription medication in Finland,
individuals must have access to non-emergency public
health coverage for which they need a municipality of
residence. Individuals must therefore be a citizen of
Finland, Switzerland, Lichtenstein, or a Nordic or EU
country, or have a valid residence permit with the dem-
onstrable intention to live in Finland for more than 1
year. In the Finnish system, at the point of access, inter-
preters are available for those who do not speak Finnish
or Swedish. Individuals must pay for their prescriptions
but those covered by the Finnish national health insur-
ance can have part of the cost reimbursed by the Social
Insurance Institution of Finland [20].
Individuals who had purchased at least 1 prescription
for an antidepressant medication within the index period
were recorded as having accessed antidepressant medi-
cation and were compared to those who had not pur-
chased an antidepressant medication during the follow-
up. This method has been used in past research using
prescription data (e.g. in Northern Ireland [21]).
Migrant group
Using data from the Finnish Population Registry, it was
possible to derive 12 first-generation migrant groups
using country of birth, namely; those born in Russia or
the former Soviet Union, Estonia, Sweden, Eastern EU
countries, the Former Yugoslavia, Western European
countries, other Western countries, North Africa or the
Middle East, sub-Saharan Africa, Central and South
America, East Asia, and South Asia. All those born in
Finland were categorised as the settled majority for the
purposes of comparison.
Covariates
Possible confounders relevant for antidepressant use
were included as covariates in the analysis. Sex, age,
marital status, taxable individual income (which includes
employment salaries, welfare benefits and capital gains),
and occupational status (categorised as self-employed,
higher [e.g. doctors and teachers] or lower [e.g. shop
salesperson, nurses] non-manual workers, manual
worker [e.g. construction workers, bus drivers, cleaners],
students and other [retired, unemployed, or unknown]),
were obtained from Statistics Finland. Those whose
main activity was household work were classified ac-
cording to the occupation of the head of the household.
With internationally high labor force participation rates
for women [22], the majority of both women and men
were allocated to socio-economic classes on the basis of
their own current or previous occupations. The accuracy
of assigned status is also supported by the stability of
socio-economic status in Finland by mid-adulthood [23].
Statistical analysis
Descriptive statistics (frequencies, percentages and χ2)
were conducted to identify socio-demographic differ-
ences between migrant groups and the Finnish settled
majority. Antidepressant use was compared between mi-
grant groups and the settled majority using two Cox
proportional hazard models, the first adjusted only for
age and the second adjusted for other socio-
demographic covariates. The Finnish-born majority were
set as the reference group for both models. The follow-
up period started from January 1, 2008, and ended at the
first record of the psychotropic medication purchase,
death, or on December 31, 2014. An analysis of scatter-
plots (logneglog-plot) confirmed that the data met the
proportional-hazards assumption. Confidence intervals
were set at 95%.
An interaction effect was tested for gender and coun-
try of birth on antidepressant use. A fully adjusted Cox
proportional hazard model with this interaction term in-
cluded showed a significant interaction (χ2 (12, n = 1,
059,426) = 47.56, p < .001), indicating that the relation-
ship between country of birth and antidepressant use is
modified by gender. All models were therefore stratified
by gender.
Data was analysed using SAS software (Version 9.4 of
the SAS System for Windows, Copyright© 2013).
Results
The total sample of working age adults was 1,059,426
(49.8% women), 26,734 (2.5%) of whom were born out-
side of Finland (52.1% women). Socio-demographic
characteristics are displayed in Table 1, and indicate a
relatively young first generation migrant population
compared to the Finland-born majority, with a greater
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number married, except for migrants from Sweden.
Gender comparisons (available on request) showed that
female migrants from Sweden, Western Europe and
Other Western countries had higher percentages of
higher non-manual employment than the Finnish major-
ity; male migrants from Estonia had a higher percentage
of manual workers; and male migrants from Sweden,
Western Europe, Eastern EU and Other Western coun-
tries had higher percentages of higher non-manual em-
ployment. A higher percentage of the Finnish majority
earned over €23,000 per year than all other migrant
groups except migrants from Sweden. In addition, mi-
grants were more likely to live in the capital Helsinki
than the Finnish-born, with the exception of Swedish
migrants (see Additional file 1: Table S1).
Greater purchases of antidepressant medication were
by female migrants from Estonia, Former Yugoslavia,
North Africa/Middle East and Other Western countries,
for divorced men and women, and by those who were
not employed and had low incomes. A large gender dif-
ference is notable, with overall 27.5% of women purchas-
ing antidepressants during the follow-up, compared to
only 18.9% of men.
Gender stratified Cox proportional hazard models are
displayed in Table 2. They show that compared to the
Finland-born majority, female and male migrants from
North Africa and the Middle East, who are likely to in-
clude the highest number of refugees and asylum
seekers, had the highest hazard of antidepressant use
(HR 1.42, 95% CI 1.32–1.54; HR 1.52, 95% CI 1.39–1.67,
respectively). This hazard lowered after adjustment for
socio-demographic factors (marital status, occupation,
and income); although for women it remained
significantly higher than for Finnish women (HR 1.18,
95% CI 1.08–1.30). Women from Estonia and former
Yugoslavian countries also had significantly higher use
of antidepressants than the Finnish majority (HR 1.11,
95% CI 1.01–1.22; HR 1.22, 95% CI 1.07–1.40, respect-
ively), but the HRs attenuated after adjustment for
socio-demographic factors such that both groups were
comparable to the female Finland-born majority.
The models further show that most male migrants had
a significantly lower use of antidepressants compared to
the Finnish majority. After adjustment for socio-
demographic characteristics, all male migrant groups
had either lower or comparable use. Women from
Sweden and other Western and Eastern European coun-
tries also had comparable use with Finland-born women,
which was not affected by socio-demographic factors,
whilst women from Russia and the former USSR (HR
0.81, 95% CI 0.77–0.85), East Asia (HR 0.46, 95% CI
0.40–0.54), South Asia (HR 0.72, 95% CI 0.54–0.96),
South and Central America (HR 0.54, 95% CI 0.42–
0.68), and Sub-Saharan Africa (HR 0.53, 95% CI 0.41–
0.69) all had significantly lower use than the Finnish ma-
jority, with no change after adjustment for socio-
demographic factors. A sensitivity analysis was con-
ducted using the follow-up period of 2006–2014, and no
significant differences were found in the results.
Discussion
To our best knowledge this is the largest register-based
long-term follow-up study on the hazards of antidepres-
sant use among migrants representing a large variety of
countries of origin. Antidepressant use was found to
vary dependent on country or region of birth and by
Table 2 Cox proportional hazard models for antidepressant use by migrant groups and the Finnish majority, stratified by gender
Country or region of
birth
Women Men
N/Events Age adjusted
HR (95% CI)
Fully adjusteda
HR (95% CI)
Age adjusted
HR (95% CI)
Fully adjusteda
HR (95%CI)
Finland 1,032,692/239773 1.00 1.00 1.00
Estonia 2433/575 1.11 (1.01–1.22) 1.00 (0.91–1.10) 0.69 (0.59–0.82) 0.65 (0.54–0.77)
Sweden 1451/328 0.99 (0.86–1.14) 1.02 (0.88–1.17) 0.98 (0.82–1.15) 0.99 (0.84–1.17)
Russia/former USSR 9003/1757 0.81 (0.77–0.85) 0.67 (0.63–0.71) 0.58 (0.53–0.64) 0.50 (0.45–0.55)
North Africa / Middle East 3602/1096 1.52 (1.39–1.67) 1.18 (1.08–1.30) 1.42 (1.32–1.54) 0.99 (0.92–1.07)
Western Europe 2604/517 0.91 (0.78–1.06) 0.87 (0.75–1.01) 0.91 (0.82–1.01) 0.85 (0.76–0.94)
East Asia 1981/225 0.46 (0.40–0.54) 0.40 (0.34–0.47) 0.38 (0.30–0.48) 0.30 (0.24–0.39)
Former Yugoslavia 1466/378 1.22 (1.07–1.40) 1.00 (0.87–1.14) 1.07 (0.92–1.24) 0.83 (0.71–0.97)
Sub-Saharan Africa 1028/149 0.53 (0.41–0.70) 0.43 (0.33–0.57) 0.70 (0.57–0.85) 0.51 (0.42–0.63)
Eastern EU 1084/241 0.99 (0.85–1.15) 0.92 (0.79–1.08) 0.82 (0.66–1.02) 0.77 (0.62–0.95)
South/Central America 890/136 0.54 (0.42–0.68) 0.37 (0.29–0.47) 0.77 (0.60–0.97) 0.53 (0.42–0.67)
South Asia 705/133 0.72 (0.54–0.96) 0.64 (0.48–0.86) 0.91 (0.75–1.13) 0.78 (0.63–0.96)
Other Western 487/112 1.14 (0.87–1.44) 1.11 (0.85–1.46) 0.97 (0.75–1.25) 0.89 (0.69–1.15)
a Adjusted for age, marital status, occupational class, and income
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gender. The findings show higher use of antidepressants
compared to the Finland-born majority for migrants
from North Africa and the Middle East, and female
migrants from Estonia and former Yugoslavia, that was
reduced after adjustment for socio-demographic charac-
teristics. Female migrants from North Africa and the
Middle East were the only migrant group with a higher
risk of antidepressant use after adjustment for socio-
demographic factors, including occupational status and
income. In sharp contrast, all male migrants had lower
or comparable use after adjustment for socio-
demographic factors, whilst women from non-Western
countries and Russia and the former USSR had lower
use than the Finland-born majority.
The higher use of antidepressant medication for mi-
grants from North Africa and the Middle East is in keep-
ing with past research in Finland that found more
hospital admissions for an ICD-10 mental disorder for
migrants from North Africa and the Middle East [16], a
higher risk of depressive symptoms for Kurdish migrants
from Iran and Iraq, particularly women [10], and in
Denmark a higher likelihood of having a first-time psy-
chiatric contact for refugees from Iraq and the Middle
East compared to native Danes [11]. This higher use is
most likely explained by the high number of asylum
seekers and refugees from these countries, who are more
likely to have been exposed to violence, displacement
and forced migration [5], traumatic events [24], preju-
dice and discrimination [25] and to social disadvantage
and insecurity in housing, employment, and education
[4]. Internationally, refugees and asylum seekers have
been found to be at higher risk of a range of psychiatric
disorders [3]. The higher use for women from these
countries even after adjustment for socio-demographic
factors, may indicate that women may be more at risk of
affective disorders or more able to access psychotropic
medication regardless of their socio-demographic cir-
cumstances. The higher use of antidepressants in women
may be explained by the disproportionate effects of dis-
placement on female asylum seekers, who face higher
risks of sexual exploitation, abuse, and domestic violence
[26], while the low use in men by poorer help seeking
caused by gendered stigma of mental illness in which
mental illness and help seeking behaviors are seen as
weaknesses [27].
The higher use of antidepressants amongst women
from Estonia and the former Yugoslavia compared to
the Finland-born majority changed to a comparable level
after adjustment for socio- demographic characteristics,
and may reflect that the poorer mental health of migrant
women from these countries is strongly affected by so-
cial disadvantage. The link between social disadvantage
and depression is well established [28] and may be of
particular relevance to women from Estonia and the
former Yugoslavia due to traditional gender roles that
place additional pressures and daily stressors on women
(e.g. in Estonia [29]). This is supported by the finding
that female migrants from culturally or socio-politically
similar countries, such as Sweden and Western Europe,
had comparable antidepressant use with their Finland-
born peers.
However, the explanation of the burden of gender role
differences is not supported by the finding that women
from countries with equally traditional gender roles,
such as from South Asia [30], had a lower use of antide-
pressants compared to the Finland-born majority. Lower
use for those from non-Western countries may therefore
be better explained by lower mental health service use.
This may be explained by a range of barriers to care, in-
cluding structural discrimination (such as long term
residence requirements to access the Finnish national
health insurance), language barriers, and differences in
help seeking behaviours [31]. In addition, the lower use
of antidepressants in first-generation migrants may be
explained by the ‘healthy migrant effect.’ Some studies
have found a protective effect of migrant status for
newly arrived migrants. This effect is thought to be due
to a selection bias where the healthiest people are the
ones to migrate, hence the term ‘healthy migrant effect,’
as well as a delayed effect of social disadvantage [32]. As
this study could not adjust for time since arrival, it is
possible that migrants from non-Western countries, and
from Russia and the former USSR, have a larger propor-
tion of newly arrived migrants than those from Western
countries. This is supported by Finnish population statis-
tics that shows an increasing proportion of migrants to
Finland from non-EU countries, predominantly from
Iraq, Russia and Afghanistan [33] and studies in coun-
tries with long established first and second generation
migrants that found high levels of depression in these
groups (e.g. in the Netherlands [12]). Migrants from
non-Western countries may therefore be displaying a
healthy migrant effect, where they have better mental
health than both the majority population and migrant
groups with a longer duration of residence. This theory
is supported by a register-based study in Sweden that
found lower use of psychotropic medication by newly ar-
rived migrants, which increased with duration of resi-
dence [7]. It may also explain the discrepancy with past
research in Finland for Russian migrants, which found
higher than average self-reported depression but used a
smaller sample size derived from an older dataset [14].
For female migrants from the Middle East, who had a
higher risk of antidepressant use, it is arguable that the
healthy migrant effect is not as salient for this group
given the high number of asylum seekers and associated
pre-migration traumatic experiences. Aside from a pos-
sible lower duration of residence bias, some migrant
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groups may have a lower risk of depression due to a
lower risk in their country of origin, such as for East
Asia [34], coupled with a relatively high risk within the
general Finnish population [16].
Migrants from Sub-Saharan Africa, predominantly
from Somalia [33], are also likely to include a high pro-
portion of displaced people and asylum seekers [35] who
have been exposed to mass violence and organised con-
flict [36, 37]. They are also more likely to live in the cap-
ital city than the Finnish-born, which has been
associated with a higher risk of mental disorders [38].
The low use of antidepressants is therefore unlikely to
be reflective of lower incidence of affective disorders.
The finding is in keeping, however, with past research in
Finland, which found comparable levels of depression
between migrants from Somalia and the Finnish popula-
tion average [14], and in Sweden which found lower
rates of psychotropic drug dispensation for refugees
from the Horn of Africa compared to the Swedish-born
population [7]. These findings were explained by a high
level of stigma and a low response rate [14], and struc-
tural barriers to care [7], respectively. There are three
key reasons why migrants from Somalia may not access
antidepressant medication, beyond that of not having a
mental health difficulty. Firstly, the level of social stigma
associated with poor mental health and the foreignness
of conceptualising difficulties as a psychological disorder
has been found across the Somalian diaspora [15, 39] in-
cluding in Finland [40], and is likely to lead to fewer So-
malian migrants seeking services for depression, or
indeed conceptualising their symptoms as depression.
Second, Somalian migrants may be more likely to access
support for psychiatric distress through family, commu-
nity and religious networks, bypassing formal services
[41]. Finally, even for those that seek medical attention
for a psychiatric problem, migrants are faced with struc-
tural, practical and institutional barriers in accessing
health services [42], challenges that are more pro-
nounced for ‘visible’ minorities [43]. It should be noted,
however, that lower antidepressant purchases could re-
flect a lower incidence of affective disorders in this
population. Migrants from sub-Saharan Africa may in-
deed have better mental health than the Finnish major-
ity. Aside from the risk factors of exposure to violence
and discrimination that may worsen the mental health
of this population, there are a number of protective fac-
tors, such as a strong culture of family and community
support [38], and healthier behaviours such as lower al-
cohol use [44], both of which have been associated with
better mental health [45, 46].
Strengths and limitations
This study is the first of its kind to identify the effect of
migrant status on antidepressant use drawing on record
linkage methodology in Finland, and benefits from com-
prehensive, representative and robust data on prescrip-
tion purchases, with no loss to follow up. The main
limitation to the study is not having data on the clinical
indication for an antidepressant prescription, as anti-
depressant medications may be prescribed for a number
of disorders other than depression and anxiety, such as
chronic pain and insomnia. However, many of these
conditions are likely to be co-morbid or have a recipro-
cal relationship, such as the high risk of depression and
antidepressant use for chronic diseases like diabetes [47].
The study is also limited by not having a measure of
other medications, the discontinuation of medication or
on the pattern of use, and by not having a measure of a
history of mental disorders or duration of residence. The
latter is likely to have influenced the rates of antidepres-
sant medication uptake in this sample, particularly for
migrant groups with higher proportions of newly arrived
migrants. The study also has a limited measurement of
socio-economic status using income and occupation that
may underestimate other types of disadvantage in some
migrant groups such as poor social capital and exposure
to racism [48] and by clustering countries with very
small numbers (such as migrants from Oceania), the
study may miss some country, regional and local socio-
demographic, cultural, and political differences. Further-
more, the perception of mental health, medication use
and the medicalisation of mental health differs between
countries and cultures, which may impact the validity of
antidepressant purchases as a proxy for both antidepres-
sant consumption [49], and for common mental health
disorders more generally [3]. Finally, the study misses
undocumented migrants or migrants without a resident
permit, which may underestimate the levels of underuse
of services in migrant populations.
Implications and conclusions
This record-linkage cohort study found differential use of
antidepressant medications dependant on country of birth
and gender. After adjustment for socio-demographic fac-
tors, female migrants from North Africa and the Middle
East had a significantly higher likelihood of purchasing
antidepressant medications. Female migrants from West-
ern countries and regions (Estonia, Sweden, Western Eur-
ope, Former Yugoslavia, Eastern EU, and other Western)
had a comparable use of antidepressant medication, whilst
female migrants from all other countries and regions
(Russia/former USSR, East Asia, Sub-Saharan Africa,
South/Central America, and South Asia) had a lower use
than the Finnish-born comparison group. Only male mi-
grants from Sweden, other Western countries (such as the
USA, Canada, Australia and New Zealand), and North-
Africa and the Middle East, had a comparable use of anti-
depressant medication, whilst male migrants from all
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other countries and regions had a lower use compared to
the Finnish-born. Overall, these results indicate an under-
use of voluntary primary care services for common mental
health disorders, particularly for men and for migrants
from non-Western countries. This supports previous re-
search on the barriers to mental health care for migrants
[1, 9], particularly for primary care [3], and has implica-
tions for service provision in Finland and beyond. Greater
focus on increasing access to primary care services for mi-
grant groups, predominantly those coming from outside
of the Western context, is clearly needed. Not only could
this relieve the distress of common mental disorders for
those affected but it could also relieve the pressure on sec-
ondary services [27]. Evidence for best practice in improv-
ing access to primary care services for vulnerable migrant
groups includes community engagement, training health
care providers in culturally sensitive health services,
lower-cost care services, free multilingual materials, and
free interpretative services [50]. In conclusion, the lower
use of antidepressant medication by most migrant groups
provides strong evidence for the under use of mental
health care and the need for improved accessibility for
these groups.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12939-019-1060-9.
Additional file 1: Table S1. Descriptive statistics showing area of
residence by country or region of birth.
Acknowledgments
Not applicable.
Authors’ contributions
AK and AV designed and conceptualized the study, and directed the
implementation of the study. TB drafted the article. AV and AK contributed
to acquisition of data. AB and AK performed the data analysis. TB, AV, AB, AK,
DO’R, AA and AK contributed to the study design, interpreting findings,
reviewing the article and revising it critically for important intellectual
content. All authors approved the manuscript’s submission for publication.
Funding
This study was funded by the Economic and Social Research Council (ESRC)
(grant ES/L007509/1 for the Administrative Data Research Northern Ireland).
The data collection from the Statistics Finland and AV and AKos were
supported by the Academy of Finland (grant 267172). DOR and AKou were
also supported by the Medical Research Council (MRC) (grant MR/K023241/
1). AKou was additionally supported by the Academy of Finland (grant
312310 for the Centre of Excellence for Research on Ageing and Care, RG 3
Migration, Care and Ageing).
Availability of data and materials
The data that support the findings of this study are available from Statistics
Finland but restrictions apply to the availability of these data, and so are not
publicly available. Data are however available from the authors upon
reasonable request and with the permission of Statistics Finland.
Ethics approval and consent to participate
The study was given ethical approval by the Finnish Institute of
Occupational Health and adheres to the ethical standards set out by the
Helsinki Declaration of 1975, revised in 2008.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1Department of Psychology, American University of Beirut, Beirut, Lebanon.
2Administrative Data Research Centre - Northern Ireland, Centre for Public
Health, Queen’s University Belfast, Belfast, UK. 3Finnish Institute of
Occupational Health, Helsinki, Finland. 4School of Social Policy, Sociology and
Social Research, University of Kent, Canterbury, UK. 5Faculty of Social
Sciences, University of Helsinki, Helsinki, Finland. 6Finnish Institute of
Occupational Health, Helsinki, Finland. 7UKCRC Centre of Excellence for
Public Health (Northern Ireland), Queen’s University Belfast, Belfast, UK. 8SWPS
University of Social Sciences and Humanities in Wroclaw, Wroclaw, Poland.
Received: 15 March 2019 Accepted: 25 September 2019
References
1. Close C, Kouvonen A, Bosqui T, Patel K, O’Reilly D, Donnelly M. The mental
health and well-being of first generation migrants: a systematic-narrative
review of reviews. Glob Health. 2016;12:47.
2. Mindlis I, Boffetta P. Mood disorders in first- and second-generation
immigrants: systematic review and meta-analysis. Bri J Psychiatr. 2017;210(3):
182–9.
3. Patel K, Kouvonen A, Close C, Väänänen A, O’Reilly D, Donnelly M. What do
register-based studies tell us about migrant mental health? A scoping
review. Syst Rev. 2017;6:78.
4. Lindert J, Ehrenstein OS, Priebe S, Mielck A, Brahler E. Depression and
anxiety in labor migrants and refugees—a systematic review and
metaanalysis. Soc Sci Med. 2009;69:246–57.
5. Fazel M, Wheeler J, Danesh J. Prevalence of serious mental disorder in 7000
refugees resettled in western countries: a systematic review. Lancet. 2005;
365:1309–14.
6. Salas-Wright CP, Vaughn MG, Goings TC. Immigrants from Mexico
experience serious behavioral and psychiatric problems at far lower rates
than US-born Americans. Soc Psychiatry Psychiatr Epidemiol. 2017;52(10):
1325–8.
7. Brendler-Lindqvist M, Norredam M, Hjern A. Duration of residence and
psychotropic drug use in recently settled refugees in Sweden – a register-
based study. Int J Equity Health. 2014;13:122.
8. Sarría-Santamera A, Hijas-Gómez AI, Carmona R, Gimeno-Feliú LA. A
systematic review of the use of health services by immigrants and native
populations. Public Health Rev. 2016;37:28.
9. Thornicroft G. Stigma and discrimination limit access to mental health care.
Epidemiol Psichiatr Soc. 2008;17(1):14–9.
10. Westman J, Johansson LM, Sundquist K. Country of birth and hospital
admission rates for mental disorders: a cohort study of 4.5 million men and
women in Sweden. Eur Psychiatry. 2006;21(5):307–14.
11. Nørredam M, Garcia-Lopez A, Keiding N, Krasnik A. Risk of mental disorders
in refugees and native Danes: a register-based retrospective cohort study.
Soc Psychiatry Psychiatr Epidemiol. 2009;44:1023–9.
12. Selten JP, Laan W, Kupka R, Smeets HM, van Os J. Risk of psychiatric
treatment for mood disorders and psychotic disorders among migrants and
Dutch nationals in Utrecht, the Netherlands. Soc Psychiatry Psychiatr
Epidemiol. 2012;47(2):271–8.
13. Patel V, Chishold D, Parikh R, Charlson FJ, Degenhardt L, et al.
Addressing the burden of mental, neurological, and substance use
disorders: key messages from disease control priorities, 3rd edition.
Lancet. 2016;387:1672–85.
14. Rask S, Suvisaari J, Koskinen S, Koponen P, Mölsä M, Lehtisalo R, Schubert C,
Pakaslahti A, Castaneda AE. The ethnic gap in mental health: a population-
based study of Russian, Somali and Kurdish origin migrants in Finland.
Scand J Public Health. 2016;44(3):281–90.
15. Palmer D. Caught between inequality and stigma: the impact of
psychosocial factors and stigma on the mental health of Somali forced
migrants in the London borough of Camden. Divers Health Social Care.
2007;4:177–91.
Bosqui et al. International Journal for Equity in Health          (2019) 18:157 Page 8 of 9
16. Markkula N, Lehti V, Gissler M, Suvisaari J. Incidence and prevalence of
mental disorders among immigrants and native Finns: a register-based
study. Soc Psychiatry Psychiatr Epidemiol. 2017;52(12):1523–40.
17. Statistics Finland. Quality guidelines for official statistics. 2nd ed. Helsinki:
Statistics Finland; 2007.
18. Lau HS, de Boer A, Beuning KS, Porsius A. Validation of pharmacy records in
drug exposure assessment. J Clin Epidemiol. 1997;50:619–25.
19. Mercier A, Auger-Aubin I, Lebeau J-P, Schuers M, Boulet P, et al. Evidence of
prescription of antidepressants for non-psychiatric conditions in primary care:
an analysis of guidelines and systematic reviews. BMC Fam Pract. 2013;14:55.
20. InfoPankki. Living in Finland: health. Helsinki: City of Helsinki; 2017.
21. Maguire A, French D, O’Reilly D. Residential segregation, dividing walls and
mental health: a population-based record linkage study. J Epidemiol
Community Health. 2016;70:845–54.
22. World Bank. (2012). Labor force participation rate, female (% of female
population ages 15+) (modeled ILO estimate). Retrieved from https://data.
worldbank.org/indicator/SL.TLF.CACT.FE.ZS.
23. Bihagen E, Nermo M. The effectiveness of ESeC and EGP in clustering
occupations: a study of occupational wage growth in Sweden. In: Rose D,
Harrison E, editors. Social class in Europe: an introduction to the European
socio-economic classification. Abingdon (Oxon): Routledge; 2010. p. 181–90.
24. Taloyan M, Johansson S-E, Sundquist J, Koctürk TO, Johansson LM.
Psychological distress among Kurdish immigrants in Sweden. Scand J Public
Health. 2008;36(2):190–6.
25. Laban CJ, Gernaat HBE, Komproe IH, van der Tweel I, De Jong JTVM.
Postmigration living problems and common psychiatric disorders in Iraqi
asylum seekers in the Netherlands. J Nerv Ment Dis. 2005;193(12):825–32.
26. Burnett A, Peel M. Health needs of asylum seekers and refugees. BMJ. 2001;
322(7285):544–7.
27. Lewer D, O’Reilly C, Mojtabai R, Evans-Lacko S. Antidepressant use in 27
European countries: associations with sociodemographic, cultural and
economic factors. BJPsych. 2015;207:221–6.
28. WHO. Social determinants of mental health. Geneva: World Health
Organization; 2014.
29. Schoon I, Hansson L, Salmela-Aro K. Combining work and family life: life
satisfaction among married and divorced men and women in Estonia,
Finland, and the UK. Eur Psychol. 2005;10:309–19.
30. Fikree FF, Pasha O. Role of gender in health disparity: the south Asian
context. BMJ. 2010;328:823.
31. Derr AS. Mental health service use among immigrants in the United States:
a systematic review. Psychiatr Serv. 2016;67(3):265–74.
32. Wu Z, Schimmele CM. The healthy migrant effect on depression: variation
over time? Can Stud Popul. 2005;32:271–95.
33. Official Statistics of Finland. Migration. Helsinki: Statistics Finland; 2016.
34. Ferrari AJ, Somerville A, Baxter AJ, Norman RE, Patten SB, Vos T, Whiteford
HA. Global variation in the prevalence and incidence of major depressive
disorder: a systematic review of the epidemiological literature. Psychol Med.
2013;43(3):471–81.
35. UNHCR. (2011). Somalia: Population movement tracking update - 14
October 2011, United Nations High Commissioner for Refugees. Retrieved
from http://www.refworld.org/docid/4e9bd1982.html.
36. Castaneda AE, Junna L, Lilja E, Skogberg N, Kuusio H, Mäki-Opas J, Koponen
P, Suvisaari J. The prevalence of potentially traumatic pre-migration
experiences: a population-based study of Russian, Somali and Kurdish origin
migrants in Finland. J Trauma Stress Disord Treat. 2017;6:1.
37. Melander E, Pettersson T, Themnér L. Organized violence, 1989-2015. J
Peace Res. 2016;53(5):727–42.
38. Penkall AM, Kohler S. Urbanicity and mental health in Europe: a systematic
review. Eur J Mental Health. 2014;9:163–77.
39. Scuglik DL, Alarcón RD, Lapeyre AC, Williams MD, Logan KM. When the
poetry no longer rhymes: mental health issues among Somali immigrants in
the USA. Transcult Psychiatry. 2007;44(4):581–95.
40. Mölsä ME, Hjelde KH, Tiilikainen M. Changing conceptions of mental distress
among Somalis in Finland. Transcult Psychiatry. 2010;47(2):276–300.
41. Ellis BH, Lincoln AK, Charney ME, Ford-Paz R, Benson M, Strunin L. Mental
health service utilization of Somali adolescents: religion, community, and
school as gateways to healing. Trans Psych. 2010;47(5):789–811.
42. Wallach-Kildemoes H, Thirstrup LT, Kriegbaum M, Petersen JH, Norredam M.
Antidepressant utilization after hospitalization with depression: a
comparison between non-Western immigrants and Danish-born residents.
BMC Psychiatry. 2014;14(77):1–11.
43. Khan, M., Kobayashi, K., Lee, S. M. & Vang, Z. (2015). (In) visible minorities in
Canadian health data and research. Population Change and Lifecourse
Strategic Knowledge Cluster Discussion Paper Series, 3(1), 5.
44. Salama E, Niemelä S, Castaneda A. Prevalence of substance use among
Russian, Somali and Kurdish migrants in Finland: a population-based study.
Eur Psychiatry. 2016;33:S315–6.
45. Lönnqvist J-E, Leikas S, Mähönen TA, Jasinskaja-Lahti I. The mixed blessings
of migration: life satisfaction and self-esteem over the course of migration.
Eur J Social Psychology. 2015;45(4):496–514.
46. Cairns KE, Yap MBH, Pilkington PD, Jorm AF. Risk and protective factors for
depression that adolescents can modify: a systematic review and meta-
analysis of longitudinal studies. J Affective Disorders. 2014;169:61–75.
47. Hofmann P. Treatment of patients with comorbid depression and diabetes
with metformin and milnacipran. Neuropsychiatr Dis Treat. 2010;6:9–15.
48. Nielsen SS, Hempler NF, Krasnik A. Issues to consider when measuring and
applying socioeconomic position quantitatively in immigrant health
research. Int J Environ Res Public Health. 2013;10:6354–65.
49. WHO. Introduction to drug utilization research. Geneva: World Health
Organization; 2003.
50. Pottie K, Batista R, Mayhew M, Mota L, Grant K. Improving delivery of
primary care for vulnerable migrants: Delphi consensus to prioritize
innovative practice strategies. Can Fam Physician. 2014;60:e32–40.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Bosqui et al. International Journal for Equity in Health          (2019) 18:157 Page 9 of 9
